XClose

UCL News

Home
Menu

UCL News

Novel botulinum compound relieves chronic pain

A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to research by UCL, the University of Sheffield and the Hospital for Sick Children, Toronto.

Publication date:

Fetal gene therapy prevents fatal neurodegenerative disease

A fatal neurodegenerative condition known as Gaucher disease can be prevented in mice following fetal gene therapy, finds a new study led by UCL, the KK Women’s and Children’s Hospital and National University Health System in Singapore.

Publication date:

Intensive care patients’ muscles unable to use fats for energy

The muscles of people in intensive care are less able to use fats for energy, contributing to extensive loss of muscle mass, finds a new study co-led by UCL, King’s College London and Guy’s and St Thomas’ NHS Foundation Trust.

Publication date:

New network of schools to share special educational needs and disability best practice

UCL Institute of Education’s (IOE) Centre for Inclusive Education and the National Association for Special Educational Needs (nasen) have formed a consortium with the aim of creating and developing a network of 10,000 schools with special educational needs and disability (SEND) at the heart of their practice over the next two years.

Publication date:

UCL statement on Tier 4 visa monitoring

In response to an incorrect and unauthorised email that was sent to some staff in one department regarding UCL’s policy on monitoring of Tier 4 students, a UCL spokesperson said: “Fines for non-compliance with Tier 4 monitoring is not UCL policy. The communication was issued in error by a member of staff and has been retracted with an apology.

Publication date: